As investments in telehealth cool, the future of the industry hinges on digital health tech solutions powered by evidence-based clinical and drug information.
Optum and Walmart are exiting the telehealth business—what do these departures signal to the virtual care industry?
Over the past several years, telehealth programs have reached new levels of adoption and acceleration. But as this inertia plateaus and some stakeholders change course, there remains untapped potential in telehealth maturity that many healthcare payers and providers have yet to access—a level where programs advance beyond an internal focus on strictly facilitating encounters and become a powerful tool to extend the care team’s reach and support the needs and outcomes of patients, members, and populations.
Continuing to grow will require virtual care providers to deliver personalized patient and member experiences grounded in clinical and drug evidence, and to support additional use cases, like medication adherence or chronic condition management.
Telehealth industry challenges: Closures signal the need for differentiation and evidence-based content
In early 2024, Walmart announced the closing of its virtual care services after five years of operation. This followed UnitedHealth Group shuttering Optum Virtual Care after news of layoffs emerged – both closures reflect broader trends of the state of the virtual care industry. Telehealth adoption has reached a saturation point (many states exceed a 90% implementation rate), leaving healthcare organizations to figure out how to differentiate, specialize, and best align with patient needs.
Providers and healthcare companies who answer these questions can tap directly into the benefits of maximizing telehealth’s potential, including:
- Bringing access to care deserts.
- Extending the reach of specializations in a time of widespread regional shortages.
- Expanding services that support patients and members as active participants in managing their health.
- Giving patients the flexibility they need and expect.
For many organizations, the path to these benefits can start with harnessing the critical role of evidence-based clinical and drug content that can easily be integrated into virtual care settings. This can provide a natural extension of care plans in a feasible and accessible manner instead of a separate initiative divided from other engagement strategies.